Respiratory Diagnostics Market Analysis by End User (Hospitals & Clinics, Reference Laboratories, and Others); by Product & Services (Assays, & Reagents, Instruments, & Devices, and Others); by Disease (Tuberculosis, Lung Cancer, Chronic Obstructive Pulmonary Disease, and Others); and by Test Type (Traditional Diagnostic, Mechanical, Imaging, Molecular Diagnostic Tests)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Product Code:
  • Published Date:
    7 Dec 2022
  • Region:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.



The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.

With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.

Market Overview:

Translate Report

 Respiratory Diagnostics Market Scope

Base Year


Forecast Year




Base Year Market Size (2022)

 ~ USD 5.0 Billion

Forecast Year Market Size (2033)

~ USD 11.0 Billion


Global Respiratory Diagnostics Market Highlights Over 2023 - 2033

The global respiratory diagnostics market is estimated to garner a revenue of USD 11.0 Billion by the end of 2033 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 5.0 Billion in the year 2022. The growth of the market can be attributed to the rising prevalence of respiratory diseases. As per the American Lung Association, there were nearly 9.0 Million adults in the year 2018 or 3.6 per cent of those ages 18 or older suffering from chronic bronchitis.






Respiratory diagnostics refers to a technique or test that helps in detecting respiratory disorders at an earlier stage.  Moreover, the respiratory disorders include asthma, COPD, lung cancer, and others from which people are suffering at a higher rate around the world.  The diagnosis of the diseases are important in order to find out the functioning of the lungs that provide oxygen and remove carbon dioxide from the body.  Furthermore, the growing number of COPD cases is projected to boost the growth of the global respiratory diagnostic market. According to the World Health Organization, chronic obstructive diseases accounted for 3.23 Million deaths in the year 2019 across the globe

Global Respiratory Diagnostics Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Geriatric Population –There is a change to the lung issue with the aging of a person and it is expected to rise the growth of the global respiratory diagnostics market.  According to the United Nations, there were approximately 703 Million people with an age of 65 years or above in the year 2019.

  • Increasing Incidence of Deaths – In the year 2020, nearly 10 Million people worldwide fell ill with tuberculosis and approximately 1.5 Million people died.

  • Rise in the Pollution Level– Nearly 2.4 Billion people are exposed to dangerous levels of household air pollution

  • Surge in the Number of Asthma Patients– In the year 2019, asthma affected approximately 262 Million people and accounted for 455000 deaths


  • Lack of Awareness

  • High Cost Related to Diagnosis and Testing

  • Lack of Reimbursement Policies by the Government

The global respiratory diagnostics market is segmented and analyzed for demand and supply by end users into hospitals & clinics, reference laboratories, and others. Out of these, the hospitals & clinics segment is anticipated to hold the largest share over the forecast period owing to the rising number of hospitals for the treatment of patients with any disease worldwide. According to the American Health Association, the total number of hospitals in the United States is represented by 6,093 in the year 2022.

Global Respiratory Diagnostics Market Regional Synopsis

Regionally, the global respiratory diagnostics market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Amongst these markets, the market in the North America region is projected to hold the largest market share by the end of 2033 on the back of the increasing prevalence of respiratory diseases, and an increase in healthcare expenditure. As per the Centers for Medicare & Medicaid Services, the United States spending in the year, 2020 grew by 9.7 percent reaching USD 12,530 per person.

Market Segmentation

Our in-depth analysis of the global respiratory diagnostics market includes the following segments:

By End User

  • Hospitals & Clinics

  • Reference Laboratories

  • Others

By Product & Services

  • Assays & Reagents

  • Instruments & Devices

  • Others

By Disease

  • Tuberculosis

  • Lung Cancer

  • Chronic Obstructive Pulmonary Disease

  • Others

By Test Type

  • Traditional Diagnostic Test

  • Mechanical Test

  • Imaging Test

  • Molecular Diagnostic Test

Customize this Report: Request Customization

Key Companies Dominating the Global Respiratory Diagnostics Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global respiratory diagnostics market that are included in our report are Koninklijke Philips N.V., General Electric Company, GlaxoSmithKline plc, Thermo Fisher Scientific Inc., Becton, Dickinson & Company, Bio-Rad Laboratories, Inc., Seegene Inc., Bayer AG, Abbott, SDI Diagnostics, and others.

Global Respiratory Diagnostics Market: Latest Developments

  • June, 2021: Koninklijke Philips N.V., announced the initiation of a voluntary recall notification for certain sleep and respiratory care products to address potential health risks associated with the polyester-based polyurethane (PE-PUR) sound abatement foam used in these devices. Following a significant increase in production, service, and repair capacity, the repair and replacement programme in the United States and several other markets has begun.

  • June, 2022: Becton, Dickinson & Company announced the CE marking of the BD MAXTM Respiratory Viral Panel (RVP), a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B, and Respiratory Syncytial Virus (RSV).

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.

  • The report includes detailed company profiles of the major players dominating the market.

  • We use effective research methodologies to calculate the market numbers and provide value-added assessments for overall growth.

  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal. 

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook



Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Koninklijke Philips N.V.
  2. General Electric Company
  3. GlaxoSmithKline plc
  4. Thermo Fisher Scientific Inc.
  5. Becton
  6. Dickinson & Company
  7. Bio-Rad Laboratories Inc.
  8. Seegene Inc.
  9. Bayer AG
  10. Abbott
  11. SDI Diagnostics 
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports